The therapeutic function of the chemokine RANTES on the H22 hepatoma ascites model

Molecular and Cellular Biochemistry

Volumn 367, Issue 1-2, 2012, Pages 93-102

  Hao, Chunfang ^a   Shi, Yehui ^a   Yu, Jinpu ^b   Wei, Xueqing ^a   Li, Shufen ^a   Tong, Zhongsheng ^a  

^a KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Anti tumor therapy; IL 2; Malignant ascites; RANTES

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES HEPATOMA; B LYMPHOCYTE; BODY WEIGHT; CANCER INVASION; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MALIGNANT ASCITES; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; T LYMPHOCYTE; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; ASCITES; CHEMOKINE CCL2; CHEMOKINE CCL5; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-2; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; TRANSFORMING GROWTH FACTOR BETA1; TUMOR BURDEN; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MURINAE; MUS;

EID: 84863431499     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1323-x     Document Type: Article

References (26)

1. Smith EM, Jayson GC (2003) The current and future management of malignant ascites. Clin Oncol (R Coll Radiol) 15:59-72 (Pubitemid 36348121)
2. Seike M, Maetani I, Sakai Y (2007) Treatment of malignant ascites in patients with advanced cancer: peritoneovenous shunt versus paracentesis. J Gastroenterol Hepatol 22:2161-2166 (Pubitemid 350145620)
3. Eissa S, Zaki SA, El-Maghraby SM, Kadry DY (2005) Importance of serum IL-18 and RANTES as markers for breast carcinoma progression. J Egypt Natl Cancer Inst 17:51-55
4. Zhang J, Wang X, Lu H (2008) Amifostine increases cure rate of cisplatin on ascites hepatoma 22 via selectively protecting renal thioredoxin reductase. Cancer Lett 260:127-136
5. Murala S, Alli V, Kreisel D, Gelman AE, Krupnick AS (2010) Current status of immunotherapy for the treatment of lung cancer. J Thorac Dis 2:237-244
6. Schall TJ, Jongstra J, Dyer BJ, Jorgensen J, Clayberger C, Davis MM, Krensky AM (2009) A human T cell-specific molecule is a member of a new gene family. 1988. J Immunol 182:3947-3954
7. Winter H, van den Engel NK, Rusan M, Schupp N, Poehlein CH, Hu HM, Hatz RA, Urba WJ, Jauch KW, Fox BA, Rüttinger D (2011) Active-specific immunotherapy for non-small cell lung cancer. J Thorac Dis 3:105-114
8. Levy JA (2009) The unexpected pleiotropic activities of RANTES. J Immunol 182:3945-3946
9. Mule JJ, Custer M, Averbook B, Yang JC, Weber JS, Goeddel DV, Rosenberg SA, Schall TJ (1996) RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. Hum Gene Ther 7:1545-1553 (Pubitemid 26302209)
10. Kutubuddin M, Federoff HJ, Challita-Eid PM, Halterman M, Day B, Atkinson M, Planelles V, Rosenblatt JD (1999) Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors. Blood 93:643-654 (Pubitemid 29035747)
11. Alexandroff AB, Jackson AM, Paterson T, Haley JL, Ross JA, Longo DL, Murphy WJ, James K, Taub DD (2000) Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Mol Immunol 37:515-526 (Pubitemid 32001693)
12. Lavergne E, Combadiere C, Iga M, Boissonnas A, Bonduelle O, Maho M, Debre P, Combadiere B (2004) Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration. J Immunol 173:3755-3762 (Pubitemid 39280737)
13. Park SJ, Hughes MA, Burdick M, Strieter RM, Mehrad B (2009) Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis. J Immunol 182:4306-4312
14. Matsumiya T, Ota K, Imaizumi T, Yoshida H, Kimura H, Satoh K (2010) Characterization of synergistic induction of CX3CL1/fractalkine by TNF-alpha and IFN-gamma in vascular endothelial cells: an essential role for TNF-alpha in post-transcriptional regulation of CX3CL1. J Immunol 184:4205-4214
15. George J, Banik NL, Ray SK (2009) Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma. Clin Cancer Res 15:7186-7195
16. Liu XS, Leerberg J, MacDonald K, Leggatt GR, Frazer IH (2009) IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host. J Immunol 183:51-58
17. Olson CM Jr, Bates TC, Izadi H, Radolf JD, Huber SA, Boyson JE, Anguita J (2009) Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis. J Immunol 182:3728-3734
18. Dodig S, Zrinski-Topić R (2009) Serial interferon gamma release assay in latent tuberculosis infection. LabMedicine 40:681-682
19. Fong YC, Hsu SF, Wu CL, Li TM, Kao ST, Tsai FJ, Chen WC, Liu SC, Wu CM, Tang CH (2009) Transforming growth factor-[beta] 1 increases cell migration and [beta] 1 integrin up-regulation in human lung cancer cells. Lung Cancer 64:13-21
20. Huang T, Kar S, Javle M (2010) Personalized therapy for pancreatic cancer: myth or reality in 2010? J Gastrointest Oncol 1:24-33
21. Prager GW, Poettler M, Unseld M, Zielinski CC (2012) Angiogenesis in cancer: anti-VEGF escape mechanisms. Transl Lung Cancer Res 1:14-25
22. Yuan Y, Chen H, Ma G, Cao X, Liu Z (2012) Reelin is involved in transforming growth factor-beta1-induced cell migration in esophageal carcinoma cells. PLoS ONE 7:e31802
23. Kuroda T, Kitadai Y, Tanaka S, Yang X, Mukaida N, Yoshihara M, Chayama K (2005) Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment. Clin Cancer Res 11:7629-7636 (Pubitemid 41611603)
24. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25:315-322 (Pubitemid 44922352)
25. Sheu BC, Hsu SM, Ho HN, Lin RH, Torng PL, Huang SC (1999) Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Cancer 86:1537-1543
26. Saiki M, Saitoh T, Inoue M, Hatta Y, Yamazaki T, Itoh T, Takeuchi J, Sawada U, Horie T (2002) Human herpesvirus-8 negative primary effusion lymphoma with complete clinical remission after removal of ascites. Rinsho Ketsueki 43:548-553